1-20 of 41
Katherine Esposito
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial

Dario Giugliano, Miriam Longo, Paola Caruso, Rosa Di Fraia, Lorenzo Scappaticcio, Maurizio Gicchino, Michela Petrizzo, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2021;44(6):1353–1360
https://doi.org/10.2337/dc20-2623
Published: 21 April 2021
View article titled, Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
Open the PDF for Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial in another window
Journal Articles

Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies

Paola Caruso, Miriam Longo, Simona Signoriello, Maurizio Gicchino, Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Dario Giugliano, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2020;43(10):e123–e124
https://doi.org/10.2337/dc20-1347
Published: 11 September 2020
View article titled, Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies
Open the PDF for Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies in another window
Journal Articles

Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047

Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2020;43(8):e105
https://doi.org/10.2337/dc20-0565
Published: 10 July 2020
View article titled, Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047
Open the PDF for Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047 in another window
Journal Articles

Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials

Maria Ida Maiorino, Simona Signoriello, Antonietta Maio, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2020;43(5):1146–1156
https://doi.org/10.2337/dc19-1459
Published: 13 April 2020
View article titled, Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials
Open the PDF for Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials in another window
Includes: Supplementary data
Journal Articles

Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425–1432

Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2018;41(2):e17
https://doi.org/10.2337/dc17-1826
Published: 12 January 2018
View article titled, Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425–1432
Open the PDF for Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425–1432 in another window
Journal Articles

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano
Journal: Diabetes Care
Diabetes Care 2017;40(4):614–624
https://doi.org/10.2337/dc16-1957
Published: 10 March 2017
View article titled, Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Open the PDF for Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials in another window
Includes: Supplementary data
Journal Articles

Primary Prevention of Sexual Dysfunction With Mediterranean Diet in Type 2 Diabetes: The MÈDITA Randomized Trial

Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Ornella Romano, Lorenzo Scappaticcio, Dario Giugliano, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2016;39(9):e143–e144
https://doi.org/10.2337/dc16-0910
Published: 28 June 2016
View article titled, Primary Prevention of Sexual Dysfunction With Mediterranean Diet in Type 2 Diabetes: The MÈDITA Randomized Trial
Open the PDF for Primary Prevention of Sexual Dysfunction With Mediterranean Diet in Type 2 Diabetes: The MÈDITA Randomized Trial in another window
Journal Articles

Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455–464

Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2016;39(7):e102–e103
https://doi.org/10.2337/dc16-0475
Published: 09 June 2016
View article titled, Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
Open the PDF for Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455–464 in another window
Journal Articles

Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S52–S59

Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2016;39(6):e86–e87
https://doi.org/10.2337/dc15-2829
Published: 13 May 2016
View article titled, Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In <em>Standards of Medical Care in Diabetes—2016</em>. Diabetes Care 2016;39(Suppl. 1):S52–S59
Open the PDF for Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In <em>Standards of Medical Care in Diabetes—2016</em>. Diabetes Care 2016;39(Suppl. 1):S52–S59 in another window
Journal Articles

Anti-inflammatory Effect of Mediterranean Diet in Type 2 Diabetes Is Durable: 8-Year Follow-up of a Controlled Trial

Maria Ida Maiorino, Giuseppe Bellastella, Michela Petrizzo, Lorenzo Scappaticcio, Dario Giugliano, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2016;39(3):e44–e45
https://doi.org/10.2337/dc15-2356
Published: 06 January 2016
View article titled, Anti-inflammatory Effect of Mediterranean Diet in Type 2 Diabetes Is Durable: 8-Year Follow-up of a Controlled Trial
Open the PDF for Anti-inflammatory Effect of Mediterranean Diet in Type 2 Diabetes Is Durable: 8-Year Follow-up of a Controlled Trial in another window
Journal Articles

Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420–1426

Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito, Dario Giugliano
Journal: Diabetes Care
Diabetes Care 2015;38(10):e168
https://doi.org/10.2337/dc15-1481
Published: 15 September 2015
View article titled, Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420–1426
Open the PDF for Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420–1426 in another window
Journal Articles

Comment on Tay et al. A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management: A Randomized Trial. Diabetes Care 2014;37:2909–2918

Maria Ida Maiorino, Michela Petrizzo, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2015;38(4):e64
https://doi.org/10.2337/dc14-2713
Published: 14 March 2015
View article titled, Comment on Tay et al. A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management: A Randomized Trial. Diabetes Care 2014;37:2909–2918
Open the PDF for Comment on Tay et al. A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management: A Randomized Trial. Diabetes Care 2014;37:2909–2918 in another window
Journal Articles

Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774

Dario Giugliano, Michela Petrizzo, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Journal: Diabetes Care
Diabetes Care 2014;37(10):e229–e230
https://doi.org/10.2337/dc14-1390
Published: 10 September 2014
View article titled, Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774
Open the PDF for Comment on Grunberger “Insulin Analogs—Are They Worth It? Yes!” Diabetes Care 2014;37:1767–1770 and Davidson “Insulin Analogs—Is There a Compelling Case to Use Them? No!” Diabetes Care 2014;37:1771–1774 in another window
Journal Articles

Comment on Home et al. Predictive and Explanatory Factors of Change in HbA1c in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237–1245

Katherine Esposito, Maria Ida Maiorino, Giuseppe Bellastella, Michela Petrizzo, Dario Giugliano
Journal: Diabetes Care
Diabetes Care 2014;37(8):e183
https://doi.org/10.2337/dc14-0705
Published: 12 July 2014
View article titled, Comment on Home et al. Predictive and Explanatory Factors of Change in HbA<sub>1c</sub> in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237–1245
Open the PDF for Comment on Home et al. Predictive and Explanatory Factors of Change in HbA<sub>1c</sub> in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237–1245 in another window
Journal Articles

The Effects of a Mediterranean Diet on the Need for Diabetes Drugs and Remission of Newly Diagnosed Type 2 Diabetes: Follow-up of a Randomized Trial

Katherine Esposito, Maria Ida Maiorino, Michela Petrizzo, Giuseppe Bellastella, Dario Giugliano
Journal: Diabetes Care
Diabetes Care 2014;37(7):1824–1830
https://doi.org/10.2337/dc13-2899
Published: 12 June 2014
View article titled, The Effects of a Mediterranean Diet on the Need for Diabetes Drugs and Remission of Newly Diagnosed Type 2 Diabetes: Follow-up of a Randomized Trial
Open the PDF for The Effects of a Mediterranean Diet on the Need for Diabetes Drugs and Remission of Newly Diagnosed Type 2 Diabetes: Follow-up of a Randomized Trial in another window
Includes: Supplementary data
Journal Articles

Simultaneous GLP-1 and Insulin Administration Acutely Enhances Their Vasodilatory, Antiinflammatory, and Antioxidant Action in Type 2 Diabetes

Antonio Ceriello, Anna Novials, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Roberto Testa, Loredana Bucciarelli, Maurizio Rondinelli, Stefano Genovese
Journal: Diabetes Care
Diabetes Care 2014;37(7):1938–1943
https://doi.org/10.2337/dc13-2618
Published: 12 June 2014
View article titled, Simultaneous GLP-1 and Insulin Administration Acutely Enhances Their Vasodilatory, Antiinflammatory, and Antioxidant Action in Type 2 Diabetes
Open the PDF for Simultaneous GLP-1 and Insulin Administration Acutely Enhances Their Vasodilatory, Antiinflammatory, and Antioxidant Action in Type 2 Diabetes in another window
Journal Articles

Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417

Katherine Esposito, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano
Journal: Diabetes Care
Diabetes Care 2014;37(5):e113
https://doi.org/10.2337/dc13-2511
Published: 10 April 2014
View article titled, Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417
Open the PDF for Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417 in another window
Journal Articles

Comment on: Raz et al. Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care 2013;36:1779–1788

Dario Giugliano, MD, PHD, Katherine Esposito, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(11):e192
https://doi.org/10.2337/dc13-1427
Published: 15 October 2013
View article titled, Comment on: Raz et al. Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections From a <em>Diabetes Care</em> Editors’ Expert Forum. Diabetes Care 2013;36:1779–1788
Open the PDF for Comment on: Raz et al. Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections From a <em>Diabetes Care</em> Editors’ Expert Forum. Diabetes Care 2013;36:1779–1788 in another window
Journal Articles

Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944

Maria Ida Maiorino, MD, Michela Petrizzo, MD, Giuseppe Bellastella, MD, PHD, Katherine Esposito, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(11):e190
https://doi.org/10.2337/dc13-1495
Published: 15 October 2013
View article titled, Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944
Open the PDF for Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944 in another window
Journal Articles

Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922

Katherine Esposito, MD, PHD, Dario Giugliano, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(10):e180
https://doi.org/10.2337/dc13-1167
Published: 14 September 2013
View article titled, Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C &lt;6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922
Open the PDF for Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922 in another window